Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.
Saved in:
| Title: | Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma. |
|---|---|
| Authors: | Jaime-Casas S; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Barragan-Carrillo R; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Zugman M; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Shah K; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Ebrahimi H; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Mercier B; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Castro DV; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Zang PD; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., LeVee A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Yip W; Division of Urology and Urologic Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Li X; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Dizman N; Department of Hematology and Oncology, MD Anderson Cancer Center, Houston, TX, United States., Salgia NJ; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States., Zengin Z; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States., Meza L; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States., Hsu J; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Nguyen CB; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Chehrazi-Raffle A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Pal SK; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Tripathi A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Oct 07; Vol. 15, pp. 1669526. Date of Electronic Publication: 2025 Oct 07 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41127009 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jaime-Casas+S%22">Jaime-Casas S</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Barragan-Carrillo+R%22">Barragan-Carrillo R</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Zugman+M%22">Zugman M</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Shah+K%22">Shah K</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Ebrahimi+H%22">Ebrahimi H</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Mercier+B%22">Mercier B</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Castro+DV%22">Castro DV</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Zang+PD%22">Zang PD</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22LeVee+A%22">LeVee A</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Yip+W%22">Yip W</searchLink>; Division of Urology and Urologic Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Dizman+N%22">Dizman N</searchLink>; Department of Hematology and Oncology, MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Salgia+NJ%22">Salgia NJ</searchLink>; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.<br /><searchLink fieldCode="AU" term="%22Zengin+Z%22">Zengin Z</searchLink>; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Meza+L%22">Meza L</searchLink>; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Hsu+J%22">Hsu J</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Nguyen+CB%22">Nguyen CB</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Chehrazi-Raffle+A%22">Chehrazi-Raffle A</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Pal+SK%22">Pal SK</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Tripathi+A%22">Tripathi A</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Oct 07; Vol. 15, pp. 1669526. <i>Date of Electronic Publication: </i>2025 Oct 07 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41127009 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2025.1669526 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1669526 Titles: – TitleFull: Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jaime-Casas S – PersonEntity: Name: NameFull: Barragan-Carrillo R – PersonEntity: Name: NameFull: Zugman M – PersonEntity: Name: NameFull: Shah K – PersonEntity: Name: NameFull: Ebrahimi H – PersonEntity: Name: NameFull: Mercier B – PersonEntity: Name: NameFull: Castro DV – PersonEntity: Name: NameFull: Zang PD – PersonEntity: Name: NameFull: LeVee A – PersonEntity: Name: NameFull: Yip W – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: Dizman N – PersonEntity: Name: NameFull: Salgia NJ – PersonEntity: Name: NameFull: Zengin Z – PersonEntity: Name: NameFull: Meza L – PersonEntity: Name: NameFull: Hsu J – PersonEntity: Name: NameFull: Nguyen CB – PersonEntity: Name: NameFull: Chehrazi-Raffle A – PersonEntity: Name: NameFull: Pal SK – PersonEntity: Name: NameFull: Tripathi A IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 10 Text: 2025 Oct 07 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |